Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 679,183 | 404,222 | 272,677 | 154,682 | 118,000 |
| Cost of Goods | 284,739 | 1,457 | N/A | 2,134 | 14,270 |
| Gross Profit | 394,444 | 402,765 | 272,677 | 152,548 | 103,720 |
| Operating Expenses | 1,264,852 | 189,346 | 141,540 | 96,823 | 62,570 |
| Operating Income | -869,669 | 213,876 | 131,137 | 55,859 | 41,430 |
| Interest Expense | 0 | 0 | 0 | 7,053 | 6,050 |
| Other Income | -10,955 | 17,646 | 30,467 | 20,541 | 10,220 |
| Pre-tax Income | -880,624 | 231,522 | 161,604 | 69,347 | 45,600 |
| Income Tax | -5,527 | 83,432 | 59,945 | 11,939 | 2,440 |
| Net Income Continuous | -875,097 | 148,090 | 101,659 | 57,408 | 43,157 |
| Net Income | $-875,097 | $148,090 | $101,659 | $48,145 | $43,150 |
| EPS Basic Total Ops | -4.92 | 0.95 | 0.67 | 0.36 | 0.35 |
| EPS Basic Continuous Ops | -4.92 | 0.97 | 0.67 | 0.43 | 0.35 |
| EPS Diluted Total Ops | -4.92 | 0.85 | 0.59 | 0.30 | 0.29 |
| EPS Diluted Continuous Ops | -4.92 | 0.84 | 0.56 | 0.36 | 0.29 |
| EBITDA(a) | $-808,361 | $224,032 | $137,443 | $60,598 | $45,790 |